Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $33,520 - $43,639
-851 Reduced 9.1%
8,496 $346,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $26,761 - $34,934
641 Added 7.36%
9,347 $478,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $862,815 - $1.05 Million
-19,717 Reduced 69.37%
8,706 $380,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $271,348 - $402,228
-6,567 Reduced 18.77%
28,423 $1.68 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $1.37 Million - $1.76 Million
34,990 New
34,990 $1.51 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $511,421 - $650,316
-15,280 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $72,866 - $85,488
2,295 Added 17.67%
15,280 $561,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $51,143 - $62,044
-1,698 Reduced 11.56%
12,985 $425,000
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $24,597 - $35,144
910 Added 6.61%
14,683 $479,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $23,834 - $27,048
724 Added 5.55%
13,773 $540,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $55,915 - $72,505
1,721 Added 15.19%
13,049 $469,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $418,909 - $470,338
11,328 New
11,328 $490,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $491,700 - $540,214
-13,112 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $29,540 - $35,831
-857 Reduced 6.14%
13,112 $578,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $270,897 - $288,804
8,214 Added 142.73%
13,969 $507,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $12,795 - $14,845
401 Added 7.49%
5,755 $204,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $165,974 - $182,839
5,354
5,354 $191,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Srb Corp Portfolio

Follow Srb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Srb Corp with notifications on news.